| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.021 | 0.6 |